Loading clinical trials...

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNPhase 3NCT01553123

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

The purpose of this study is to determine whether ulipristal acetate is effective in the treatment of females with anemia associated with uterine leiomyomas. The safety of this product will also be ev...

Lead sponsor: Watson Pharmaceuticals•47 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

NCT00552955 · Lymphangioleiomyomas, Tuberous Sclerosis, and more

COMPLETEDPhase 2

Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin

NCT00971620 · Cutaneous Leiomyomas, Hereditary Leiomyomatosis and Renal Cell Cancer

COMPLETEDPhase 3

Therapeutic MRI Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

NCT01141062 · Uterine Leiomyomas

COMPLETEDPhase 3

Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner

NCT01064960 · Uterine Leiomyomas

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 7, 2013Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE3

Enrollment—

Start dateApr 2012

Last updatedFeb 7, 2013

Condition

Leiomyomas

Locations shown

Alabama Clinical Therapeutics

Birmingham, Alabama

Coastal Clinical Research, Inc

Mobile, Alabama

Women's Health Research

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 7, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions